SA
Log In
ASND
OverviewIntelligenceChart
Earnings in 3 days · May 7, 2026 · After close
Signal
Mixed1↑1↓
Price
1↑
Move↑+1.10%Positive session
Volume
1→
Volume↓0.1× avgLight volume
Technical
1↓
RSI↓RSI 47Momentum negative
PRICE
Prev Close
220.93
Open
221.00
Day Range221.00 – 224.27
221.00
224.27
52W Range150.89 – 250.74
150.89
250.74
73% of range
VOLUME & SIZE
Avg Volume
724.8K
FUNDAMENTALS
P/E Ratio
-50.8x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
1.03
Market-like
Quick Read
Trend—Insufficient MA data
Momentum
BULLISH
revenue +97% YoY · 86% gross margin
Valuation
FAIR
P/E not available
Health
MODERATE
CR 1.0 · FCF $0.70/sh
Bullish
Key MetricsTTM
Market Cap$11.77B
Revenue TTM$717.81M
Net Income TTM-$227.72M
Free Cash Flow$42.78M
Gross Margin86.3%
Net Margin-31.7%
Operating Margin-19.0%
Return on Equity127.5%
Return on Assets-17.5%
Debt / Equity-5.35
Current Ratio1.04
EPS TTM$-3.71
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
3 strong1 watch2 concern
56/100
Liquidity
1.04Watch
Leverage
-5.35Strong
Coverage
-0.9xConcern
ROE
127.5%Strong
ROIC
-19.0%Concern
Cash
$616MStrong
ANALYST COVERAGE23 analysts
BUY
▲ +19.8%upside to target
L $250.00
Med $267.50consensus
H $342.00
Buy
2296%
Hold
14%
22 Buy (96%)1 Hold (4%)0 Sell (0%)
Full report →
Stock Health
Composite Score
1 of 4 signals bullish
4/10
Technicals
●
RSI RangeRSI 47 — Bearish momentum
✗
Fundamentals
●
Last EarningsMissed estimates
✗
●
Analyst ConsensusBuy
✓
●
LiquidityCurrent Ratio 1.04
~

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings ReportMay 5, 2026
Tomorrow
DEx-Dividend DateAug 2, 2026
In 90 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBULLISH
Technicals →

Trend

▲ UptrendGolden Cross · 50D leads 200D by 19.7%

+8.2% vs SMA 50 · +29.5% vs SMA 200

Momentum

RSI47.1
Neutral territory
MACD+2.74
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$250.7+12.3%
Current
$223.4
EMA 50
$206.5-7.5%
EMA 200
$172.5-22.8%
52W Low
$150.9-32.4%
52-Week RangeMid-range
$150.973th %ile$250.7
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 12 analysts
Full estimates →
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$708.3M
$703.1M–$719.7M
—-$3.35—
±34%
High12
FY2026(current)
$1.4B
$1.3B–$1.5B
▲ +96.0%$3.98—
±50%
High10
FY2027
$2.0B
$1.8B–$2.2B
▲ +45.0%$9.98▲ +150.6%
±43%
High10
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryASND
Last 8Q
-145.7%avg beat
Beat 3 of 8 quartersMissed 5↑ Estimates rising
-53%
Q2'24
-33%
Q3'24
+1%
Q4'24
+43%
Q1'25
-6%
Q2'25
+35%
Q3'25
-185%
Q4'25
-967%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
No recent activity
Morgan StanleyEqual-Weight → Overweight
May 5
UPGRADE
Cowen & Co.Buy → Positive
Jun 25
UPGRADE
Cowen & Co.Buy
Jun 25
UPGRADE
Financials

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
Pictet Asset Management Holding SA
252K▲
2
Candriam S.C.A.
230K▲
3
abrdn plc
210K▼
4
ARS Investment Partners, LLC
209K▲
5
BRAUN STACEY ASSOCIATES INC
131K▲
6
SG Americas Securities, LLC
121K▲
7
Perpetual Ltd
101K▲
8
Diversified Trust Co
37K▼
News & Activity

ASND News

20 articles · 4h ago

About

ascendis pharma a/s is a biotechnology company located in 12 tuborg blvd., hellerup, capital region of denmark, denmark.

Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Jan Moeller Mikkelsen
Country
Denmark
Website
ascendispharma.com ↗
Mads BodenhoffSenior Vice President, Head of Finance & Principal Accounting Officer
Michael Wolff JensenExecutive Vice President, Chief Legal Officer & Member of the Executive Board
Scott T. SmithChief Financial Officer, Executive Vice President & Member of Executive Board

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance